The Growth Trajectory of the Peripheral Stent Implant Market
The peripheral stent implant market is poised for significant growth, with a forecasted value of approximately US$ 7.76 billion by the year 2034. This upward trend indicates a compound annual growth rate (CAGR) of about 6.6% from 2024, driven by increasing demand for minimally invasive procedures to treat peripheral artery disease (PAD).
Factors Fuelling Market Expansion
One of the primary factors boosting the market is the growing preference for endovascular innovations such as stent implantation. These methods are gaining traction as preferable alternatives to traditional surgical revascularization approaches. The lower procedural risks associated with accessing arteries through minimal incisions are making stent implantation a popular choice among healthcare providers.
Benefits of Endovascular Procedures
Endovascular procedures are known for their benefits, including reduced trauma to the patient, shorter hospital stays, and faster recovery times compared to open surgeries. Many studies indicate that the long-term outcomes of these procedures are comparable to those resulting from traditional methods, offering additional reassurance to both patients and healthcare professionals.
Key Insights from Market Analysis
The analysis indicates that the global peripheral stent implant market is expected to reach a size of US$ 7.76 billion by the end of 2034. Notably, the East Asia region is set to expand at a promising CAGR of 7.9% from 2024 to 2034, while North America is projected to account for 7% of the overall market share in 2024.
Further insights reveal that sales of peripheral stent implants within the United States are anticipated to reach US$ 3.31 billion by 2034, while sales for bare metal stents (BMS) are projected to hit US$ 3.12 billion in 2024. By artery type, iliac artery stent sales are estimated to reach US$ 3.68 billion during the same period.
The Role of Drug-Eluting Stents
According to a market analyst, "Drug-eluting stents are becoming increasingly popular due to their effectiveness in reducing restenosis rates and improving long-term patient outcomes, which is pivotal for their integration into the peripheral stent implant market."
Key Players Driving Market Advances
The market is propelled by key players such as Biotronik SE & Co. KG, W. L. Gore & Associates Inc., Abbott Laboratories, Cook Medical, B. Braun Melsungen AG, and Medtronic Plc., among others, who are actively involved in innovations within the peripheral stent implant sector.
Hospitals: A Central Role in Peripheral Stent Procedures
The majority of peripheral stent implantation procedures occur in hospitals, which provide a conducive environment for patient care. Hospitals are equipped with trained medical personnel and advanced technology needed for such interventions, including specialized catheterization labs. Their established connections with medical device manufacturers also facilitate the efficient use of stent implants.
Recent Developments in the Industry
- The AGILITY investigational device exemption trial, aimed at evaluating the safety and effectiveness of a vascular-covered stent developed by Becton, Dickinson and Company for treating PAD, recently began patient enrollment.
- In October 2023, Cordis announced its acquisition of MedAlliance, a leading innovator in drug-eluting balloon technology.
- August 2021 saw Royal Philips finalize a deal to acquire Vesper Medical, known for its minimally invasive peripheral vascular devices.
- Efemoral Medical recently reported the first-in-human application of its bioresorbable vascular scaffold system aimed at improving PAD treatment outcomes.
Conclusion and Key Insights
The peripheral stent implant market exhibits a robust growth trajectory driven by innovations in minimally invasive procedures and the emergence of drug-eluting stents as a preferred choice. As companies continue to invest in research and partnerships, the future of this domain looks promising.
Frequently Asked Questions
What is the projected market size of the peripheral stent implant market by 2034?
The market is projected to reach approximately US$ 7.76 billion by 2034.
What growth rate is expected for the peripheral stent implant market?
The market is expected to grow at a CAGR of 6.6% from 2024 to 2034.
Which region is expected to grow the fastest in this market?
East Asia is forecasted to expand at a CAGR of 7.9% from 2024 to 2034.
How do endovascular techniques compare to traditional surgical methods?
Endovascular techniques are less invasive, resulting in reduced patient trauma, shorter hospital stays, and faster recovery times compared to traditional surgeries.
Who are the major players in the peripheral stent implant market?
Key players include Biotronik SE & Co. KG, Abbott Laboratories, Medtronic Plc., and Boston Scientific Corporation, driving innovation and growth in this sector.
